Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
BABA Alibaba Group Holding Ltd
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
AGNC Agnc Investment Corp
GME GameStop Corp

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Closing Price
Day's Change
1.02 (0.95%)
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

Carnival stock surges as Q1 losses widened to $2 billion but cash burn was less than expected

9:55 am ET April 7, 2021 (MarketWatch)

Shares of Carnival Corp. (CCL) jumped 4.7% in morning trading Wednesday, after the cruise operator provided a business update for the first quarter, with the net loss widening more than expected although cash burn was less than projected. The company said the net loss for the quarter swelled to $2.0 billion, after a loss of $781 million in the year-ago period and compared with the FactSet loss consensus of $1.7 billion. Meanwhile, the company said it average monthly cash burn rate for the quarter was $500 million, which was better than guidance provided in January of about $600 million. The company said it ended the first quarter with $11.5 billion in liquidity, up from $9.5 billion at the end of the fourth quarter, and said booking volumes for all futures cruises during the quarter were about 90% higher than in the fourth quarter. Carnival expects six of its nine brands to resume limited guest cruises by the summer. The business update comes a day after the company's Carnival Cruise Line said it extended the suspension of all cruises from U.S. ports through June 30, and that it may have no choice but to move its ships outside the U.S ( given Centers for Disease Control and Prevention restrictions ( The stock has run up 38.4% year to date, while the S&P 500 has gained 8.6%.

-Tomi Kilgore; 415-439-6400;


(END) Dow Jones Newswires

April 07, 2021 09:55 ET (13:55 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.